Page 37 - ISBD 2018
P. 37

POSTER ABSTRACT NUMBER DATE NUMBER
054 7-8 MARCH, 2018 ISBD8-0108
GENETICS AND PROTEOMICS
GENOME-WIDE INTERACTIONS WITH BODY MASS INDEX AND BIPOLAR DISORDER RISK: A STUDY FROM THE PSYCHIATRIC GENOMICS CONSORTIUM BIPOLAR DISORDER WORKING GROUP
Dr Cuéllar Barboza, Alfredo (Mexico)
055 7-8 MARCH, 2018 ISBD8-0086
GENETICS AND PROTEOMICS
BRAIN DERIVED NEURATROPHIC FACTOR (BDNF) VAL66MET VARIANT IS ASSOCIATED WITH EARLY ONSET BIPOLAR DISORDER ON THE GENETIC LEVEL AND EPIGENETIC LEVEL
Dr Frye, Mark (USA)
056 7-8 MARCH, 2018 ISBD8-0019
GENETICS AND PROTEOMICS
DATA MINING STUDY OF MICRORNA EXPRESSION DATASETS FROM THE POST- MORTEM FRONTAL CORTEX EXAMINING REDOX MODULATION PATHWAYS IN PATIENTS WITH BIPOLAR DISORDER
Dr Kim, Helena (Canada)
057 7-8 MARCH, 2018 ISBD8-0071
GENETICS AND PROTEOMICS
MET ALLELE OF THE RS6265 (VAL66MET) SNP OF THE BDNF GENE PRESENCE AND ITS RELATION WITH PERCEPTION OF COGNITION
Mr Toranzo, Alberto (Mexico)
058 7-8 MARCH, 2018 ISBD8-0235
INTEGRATION OF PHARMACOLOGICAL, SOMATIC AND PSYCHOLOGICAL TREATMENT
LONG-TERM EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA IN PATIENTS WITH A MOOD DISORDER
Dr Farahmand, Khodayar (USA)
059 7-8 MARCH, 2018 ISBD8-0214
INTEGRATION OF PHARMACOLOGICAL, SOMATIC AND PSYCHOLOGICAL TREATMENT
EFFICACY AND TOLERABILITY OF DIVALPROEX SODIUM PLUS ADJUNCTIVE QUETIAPINE, LITHIUM, OR PLACEBO FOR HYPOMANIC OR MANIC EPISODES IN OUTPATIENTS WITH BIPOLAR I DISORDER
Ms Fischer, E. Grace (USA)
        37









































































   35   36   37   38   39